This study has indicated that HMGB1-mediated YAP activation contributes to PFKFB3 upregulation and PASMC glycolysis, which promotes PASMC proliferation, pulmonary vascular remodeling, and ultimately the development of PAH. This evidence concerns the gene PFKFB3 and pulmonary arterial hypertension.